CSI Market
Sign In | Register

Tc Biopharm holdings Plc (TCBP) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TCBP Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Tc Biopharm holdings Plc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		0 0 (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-15.30
Depreciation & amortization0.38
Amortization of Other Assets0.05
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Finite-lived0.13
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.01
Income (Loss) from Equity Method Investments122.90
Financial Instruments and Foreign Currency Transaction0.00
Adjustments Amortization Of Intangible Assets-
Adjustments For Amortization Of Right Of Use Assets-
Adjustments For Sharebased Payments-
Gains Losses On Change In Fair Value Of Derivatives-
Finance Income-
Adjustments For Finance Costs-
Disposal Of Intangible Assets-
Adjustments For Decrease Increase In Decrease In Deferred Income-
Adjustments For Increase Decrease In Trade Account Payable-
Derivative Gain Loss On Derivative Net-
Foreign Currency Transaction Gain Loss After Tax-
Increase Decrease In In Corporation Tax Receivable-
Increase Decrease In Operating Lease Right Of Use Asset-
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.61
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.71
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-15.80
Investing Activities
Capital Expenditures-0.09
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.09
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock15.28
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.56
Increase Decrease In Cash And Cash Equivalents-
Payments Of Stock And Warrant Issuance Costs-
Issuance Costs In Connection With Exercise Of Warrants-
Proceeds From Issuance Costs In Connection With Issuance Of Ordinary Shares-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities14.71
Effect of exchange rate on cash flow-0.05
Discontinued operations0.00
Free Cash Flow-15.89
Total Cash Flow-1.25
4 historic quarters locked

Sign in to unlock the full Tc Biopharm holdings Plc cash flow history.

Sign In Create Free Account

About Tc Biopharm holdings Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240331)
  • Filed with the SEC: May 15, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-019840

Figures are derived from filed reports and may be restated. Historical data is subject to revision.